Models for the Prediction of Receptor Tyrosine Kinase Inhibitory Activity of Substituted 3-Aminoindazole Analogues
2011

Predicting Cancer Drug Activity with 3-Aminoindazole Models

Sample size: 42 publication Evidence: high

Author Information

Author(s): Monika Gupta, Harish Dureja, Anil Kumar Madan

Primary Institution: M. D. University, Rohtak, India

Hypothesis

Can topological indices predict the receptor tyrosine kinase inhibitory activity of substituted 3-aminoindazole analogues?

Conclusion

The developed models accurately predict KDR inhibitory activity and show potential for identifying effective cancer treatments.

Supporting Evidence

  • The decision tree achieved an accuracy of 88% in classifying the analogues.
  • The models showed high sensitivity and precision for predicting active and inactive compounds.
  • The average IC50 for active compounds was found to be as low as 5 nM.

Takeaway

Scientists created computer models to help find new cancer drugs by looking at how certain chemical structures work in the body.

Methodology

The study used decision tree and moving average analysis on a dataset of 42 analogues to develop predictive models.

Potential Biases

Potential bias in the selection of analogues and the methods used for analysis.

Limitations

The models may not account for all biological variability and were based on a limited dataset.

Statistical Information

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3797/scipharm.1102-08

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication